COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,889 Articles (22,568 medRxiv, 8,321 bioRxiv)

Most recent first Previous |  Page 676: Articles 6751-6760  | Next

Prevalence and factors associated with antigen test positivity following SARS-CoV-2 infection among healthcare workers in Los Angeles
Adamson, P. C., Currier, J. S., Uslan, D. Z., Garner, O. B.
10.1101/2022.07.06.22277341 — Posted: 2022-07-07
Association between nursing home crowding and outbreak-associated respiratory infection and death prior to the COVID-19 pandemic between 2014 and 2019 in Ontario, Canada
Leece, P., Whelan, M., Costa, A. P., Daneman, N., Johnstone, J., McGeer, A., Rochon, P., Schwartz, K. L., Brown, K. A.
10.1101/2022.07.06.22277066 — Posted: 2022-07-07
PERSISTENT IMMUNITY AFTER MILD SARS CoV-2 INFECTION - THE CoNAN-LONG TERM STUDY -
Schnizer, C., Andreas, N., Varela, W. V., Kamradt, T., Baier, M., Kiehntopf, M., Gloeckner, S., Scherag, A., Loeffler, B., Kolanos, S., Guerra, J., Pletz, M., Weis, S.
10.1101/2022.07.05.22277237 — Posted: 2022-07-07
Duration of immune protection of SARS-CoV-2 natural infection against reinfection in Qatar
Chemaitelly, H., Nagelkerke, N., Ayoub, H., Coyle, P., Tang, P., YASSINE, H. M., Al-Khatib, H. A., Smatti, M. K., Hasan, M. R., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G., Al-Kuwari, M. G., Butt, A. A., Al-Romaihi, H. E., Al-Thani, M. H., Al-Khal, A., Bertollini, R., Abu-Raddad, L. J.
10.1101/2022.07.06.22277306 — Posted: 2022-07-07
Multimodal surveillance of SARS-CoV-2 at a university enables development of a robust outbreak response framework
Petros, B. A., Paull, J. S., Tomkins-Tinch, C. H., Loftness, B. C., DeRuff, K. C., Nair, P., Gionet, G. L., Benz, A., Brock-Fisher, T., Hughes, M., Yurkovetskiy, L., Mulaudzi, S., Leenerman, E., Nyalile, T., Moreno, G. K., Specht, I., Sani, K., Adams, G., Babet, S. V., Baron, E., Blank, J. T., Boehm, C., Botti-Lodovico, Y., Brown, J., Buisker, A. R., Burcham, T., Chylek, L., Cronan, P., Desreumaux, V., Doss, M., Flynn, B., Gladden-Young, A., Glennon, O., Harmon, H. D., Hook, T. V., Kary, A., King, C., Loreth, C., Marrs, L., McQuade, K. J., Milton, T. T., Mulford, J. M., Oba, K., Pearlman, L., Schifferli, M., Schmidt, M. J., Tandus, G. M., Tyler, A., Vodzak, M. E., Bevill, K., Colubri, A., MacInnis, B. L., Ozsoy, A. Z., Parrie, E., Sholtes, K., Siddle, K. J., Fry, B., Luban, J., Park, D. J., Marshall, J., Bronson, A., Schaffner, S. F., Sabeti, P. C.
10.1101/2022.07.06.22277314 — Posted: 2022-07-07
Proximity to livestock farms and COVID-19 in the Netherlands, 2020-2021
Hogerwerf, L., Post, P. M., Bom, B., van der Hoek, W., van de Kassteele, J., Stemerding, A., de Vries, W., Houthuijs, D.
10.1101/2022.07.05.22277177 — Posted: 2022-07-07
A Novel Regioselective Approach to Cyclize Phage-Displayed Peptides in Combination with Epitope-Directed Selection to Identify a Potent Neutralizing Macrocyclic Peptide for SARS-CoV-2
Hampton, J. T., Lalonde, T. J., Tharp, J. M., Alugubelli, Y. R., Roundy, C. M., Hamer, G. L., Xu, S., Liu, W. R., Kurra, Y.
10.1101/2022.07.06.498864 — Posted: 2022-07-06
Understanding The Role of Heparinoids on the SARS-CoV-2 Spike Protein through Molecular Dynamics Simulations
Pipito, L., Reynolds, C. A., Deganutti, G.
10.1101/2022.07.05.498807 — Posted: 2022-07-06
How long and effective does a mask protect you from an infected person who emits corona virus-laden particles: by implementing physics-based modeling
Bahrami, F., Batt, T., Schudel, S., Annaheim, S., He, W., Wang, J., Rossi, R. M., Defraeye, T.
10.1101/2022.07.05.22277221 — Posted: 2022-07-06
Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance.
Flisiak, R., Zarebska-Michaluk, D., Rogalska, M., Krynska, J. A., Kowalska, J., Dutkiewicz, E., Dobrowolska, K., Jaroszewicz, J., Moniuszko-Malinowska, A., Rorat, M., Podlasin, R., Tronina, O., Rzymski, P.
10.1101/2022.07.05.22277227 — Posted: 2022-07-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).